There are currently about 17,000 people awaiting liver transplants in the United States alone. This number far exceeds the number of livers available from deceased donors. On top of that, organ transplants are prohibitively expensive. In 2017, the cost of a liver transplant, including pre and post-op care and drugs to prevent the body from rejecting the transplant, was north of $800,000. A recent INVERSE article discussed a new lab-grown option that aims to tackle that waitlist and create a future free of organ donors.
Quick Hits: Lab-Grown Livers Could Revolutionize Organ Transplants
Scientists created fully-functional mini-livers and successfully transplanted them into rats.
Jun 11, 2020
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
